PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 27.75
+1.60 (6.12%)
Aug 14, 2025, 5:31 PM CET
PolyPeptide Group AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Operating Revenue | 368.85 | 336.79 | 320.37 | 280.98 | 282.13 | 223.03 | Upgrade
|
| Other Revenue | - | - | - | - | - | 1.26 | Upgrade
|
| Revenue | 368.85 | 336.79 | 320.37 | 280.98 | 282.13 | 224.3 | Upgrade
|
| Revenue Growth (YoY) | 13.99% | 5.13% | 14.02% | -0.41% | 25.78% | 10.26% | Upgrade
|
| Cost of Revenue | 327.33 | 299.31 | 315.6 | 228.99 | 182.43 | 151.11 | Upgrade
|
| Gross Profit | 41.52 | 37.49 | 4.77 | 51.99 | 99.7 | 73.19 | Upgrade
|
| Selling, General & Admin | 48.69 | 44.25 | 41.54 | 40.63 | 32.5 | 28.01 | Upgrade
|
| Research & Development | 1.55 | 1.1 | 1.47 | 1.24 | 1.41 | 1.31 | Upgrade
|
| Other Operating Expenses | -1.62 | -1.9 | -4.4 | -2.41 | -1.61 | -0.45 | Upgrade
|
| Operating Expenses | 48.62 | 43.44 | 38.6 | 39.46 | 32.3 | 28.88 | Upgrade
|
| Operating Income | -7.11 | -5.95 | -33.83 | 12.53 | 67.4 | 44.31 | Upgrade
|
| Interest Expense | -30.85 | -13.85 | -5.62 | -2.09 | -2.82 | -3.32 | Upgrade
|
| Interest & Investment Income | - | 0.59 | 0.05 | 0.01 | 0.01 | 0.11 | Upgrade
|
| Currency Exchange Gain (Loss) | 6.18 | 6.18 | -14.5 | -1.63 | -1.87 | -3.16 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.63 | -3.63 | -1.63 | -1.25 | -0.17 | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | -35.4 | -16.66 | -55.52 | 7.57 | 62.55 | 38.01 | Upgrade
|
| Asset Writedown | -1.49 | -1.49 | -2.72 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -2.71 | -0.33 | Upgrade
|
| Pretax Income | -36.89 | -18.15 | -58.24 | 7.57 | 59.85 | 37.69 | Upgrade
|
| Income Tax Expense | -2.17 | 1.42 | -6.8 | -0.2 | 12.59 | 6.35 | Upgrade
|
| Net Income | -34.72 | -19.56 | -51.44 | 7.77 | 47.26 | 31.34 | Upgrade
|
| Net Income to Common | -34.72 | -19.56 | -51.44 | 7.77 | 47.26 | 31.34 | Upgrade
|
| Net Income Growth | - | - | - | -83.56% | 50.81% | 21.75% | Upgrade
|
| Shares Outstanding (Basic) | 33 | 33 | 33 | 33 | 32 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 33 | 33 | 33 | 32 | 30 | Upgrade
|
| Shares Change (YoY) | 1.74% | 0.10% | -0.11% | 2.74% | 7.08% | - | Upgrade
|
| EPS (Basic) | -1.04 | -0.59 | -1.56 | 0.24 | 1.47 | 1.04 | Upgrade
|
| EPS (Diluted) | -1.04 | -0.59 | -1.56 | 0.24 | 1.47 | 1.04 | Upgrade
|
| EPS Growth | - | - | - | -83.98% | 41.35% | - | Upgrade
|
| Free Cash Flow | 32.53 | 3.65 | -16.41 | -69.64 | -16.61 | 8.86 | Upgrade
|
| Free Cash Flow Per Share | 0.98 | 0.11 | -0.50 | -2.11 | -0.52 | 0.29 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.289 | - | Upgrade
|
| Gross Margin | 11.26% | 11.13% | 1.49% | 18.50% | 35.34% | 32.63% | Upgrade
|
| Operating Margin | -1.93% | -1.77% | -10.56% | 4.46% | 23.89% | 19.76% | Upgrade
|
| Profit Margin | -9.41% | -5.81% | -16.06% | 2.76% | 16.75% | 13.97% | Upgrade
|
| Free Cash Flow Margin | 8.82% | 1.08% | -5.12% | -24.79% | -5.89% | 3.95% | Upgrade
|
| EBITDA | 19.84 | 18.28 | -12.31 | 33.05 | 83.46 | 58.44 | Upgrade
|
| EBITDA Margin | 5.38% | 5.43% | -3.84% | 11.76% | 29.58% | 26.05% | Upgrade
|
| D&A For EBITDA | 26.95 | 24.23 | 21.52 | 20.53 | 16.06 | 14.13 | Upgrade
|
| EBIT | -7.11 | -5.95 | -33.83 | 12.53 | 67.4 | 44.31 | Upgrade
|
| EBIT Margin | -1.93% | -1.77% | -10.56% | 4.46% | 23.89% | 19.76% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 21.04% | 16.85% | Upgrade
|
| Revenue as Reported | 370.54 | 338.77 | 324.85 | 283.46 | 286.22 | 224.81 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.